Zydus gets USFDA nod for Lamotrigine Extended-Release Tablets for seizures Medical Dialogues Bureau3 April 2020 1:32 PM ISTAhmedabad: Zydus Cadila has received final approval from the USFDA to market Lamotrigine Extended-Release Tablets USP in the strengths of 25 mg, 50...
J&K sets up PMRU of NPPA to fight coronavirus Medical Dialogues Bureau3 April 2020 11:45 AM ISTDelhi: Jammu & Kashmir Union Territory has become 12th State where the Price Monitoring & Resource Unit (PMRU) has been set up by the National...
Intas Contributes two million tablets of hydroxychloroquine for Global Trials Against COVID-19 Medical Dialogues Bureau3 April 2020 10:15 AM ISTIntas will provide up to two million tablets of hydroxychloroquine to the trial, free of charge, along with two million tablets of matched placebo.
Jubilant gets USFDA EIR for its Solid Dosage facility at Salisbury, Maryland USA Medical Dialogues Bureau2 April 2020 2:18 PM ISTNoida: Jubilant Life Sciences Limited, an integrated global Pharmaceutical and Life Sciences Company, has announced that Jubilant Pharma Limited, a...
Mylab collaborates with Serum India CEO Adar Poonawalla, Abhijit Pawar to scale-up production of COVID-19 test kits Medical Dialogues Bureau2 April 2020 1:30 PM ISTPune: In order to scale up the operations and escalate faster delivery of testing kits for the novel coronavirus (COVID-19), Pune-based molecular...
Coronavirus: Zydus Wellness launches hand sanitizer under Nycil brand to meet growing demand Medical Dialogues Bureau2 April 2020 1:00 PM ISTNycil sanitizer consists of neem and aloevera extracts that helps kill 99.9 percent germs, Zydus Wellness said
COVID-19: US asks India to lift restrictions on export of pharmaceutical ingredients Medical Dialogues Bureau2 April 2020 9:00 AM ISTWashington: The United States officials are reportedly in contact with India asking the country to lift restrictions to give the US access to...
Biocon gets USFDA EIR with VAI Classification for its Malaysian Insulin Manufacturing Facility Medical Dialogues Bureau1 April 2020 12:44 PM ISTBengaluru: Biocon Sdn Bhd, a subsidiary of Biocon Limited has announced that it has received the Establishment Inspection Report (EIR) from the U.S....
Lilly gets USFDA nod for Taltz(ixekizumab) for Pediatric Patients with Moderate to Severe Plaque Psoriasis Medical Dialogues Bureau1 April 2020 12:30 PM ISTIndianapolis: Eli Lilly and Company have announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License...
Novalead Pharma says 42 existing drugs can help in treating coronavirus patients Medical Dialogues Bureau1 April 2020 10:00 AM ISTMumbai: Novalead Pharma on Tuesday said it has found that 42 existing drugs can be helpful in treating patients at different stages of coronavirus...
US begins stockpiling malaria medicine for treating COVID-19 patients Medical Dialogues Bureau1 April 2020 9:00 AM ISTWashington: The US has started procuring malaria medicine 'Hydroxychloroquine' for treating COVID-19 patients as it anticipates a favorable result...
Strides receives USFDA EIR for KRS Gardens, Bangalore facility Medical Dialogues Bureau31 March 2020 1:30 PM ISTBangalore: Strides Pharma Science Limited has announced that it has received the Establishment Inspection Report (EIR) for the inspection conducted by...
